Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design

Drug Delivery

Volumn 23, Issue 6, 2016, Pages 1912-1925

  Kaur, Prabhjot ^a   Garg, Tarun ^a   Rath, Goutam ^a   Murthy, R S Rayasa ^a   Goyal, Amit K ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Box Behnken design; nanolipid carrier; paclitaxel; pulmonary drug delivery; surfactant

Indexed keywords

DRUG CARRIER; LIPID; PACLITAXEL; POLYSORBATE 20; POLYSORBATE 60; POLYSORBATE 80; LUNG SURFACTANT; NANOMATERIAL; NANOPARTICLE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CONTROLLED STUDY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; EMULSION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; SOLID STATE; SPRAY DRYING; VELOCITY; CACO-2 CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RESISTANCE; HUMAN; LUNG TUMOR; MEDICINAL CHEMISTRY; METABOLISM;

CACO-2 CELLS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; HUMANS; LIPIDS; LUNG NEOPLASMS; NANOPARTICLES; NANOSTRUCTURES; PACLITAXEL; PULMONARY SURFACTANTS;

EID: 84975141177     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.993486     Document Type: Article

References (55)

1. S.Chaudhary, T.Garg, R.S.Murthy,. (2014). Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target 1–12
2. D.C.Drummond, C.O.Noble, Z.Guo,. (2010). Development of a highly stable and targetable nanoliposomal formulation of topotecan. J Control Release 141:13–21
3. J.Emami, M.Rezazadeh, J.Varshosaz. (2012). Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: a detailed study of preparation, freeze drying condition, and in vitro cytotoxicity. J Nanomater 2012:3
4. G.Gagandeep, T.Garg, B.Malik,. (2014). Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci 53:10–16
5. T.Garg, A.K.Goyal, S.Arora, R.Murthy. (2012a). Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett 2:251–61
6. T.Garg, A.K.Goyal. (2014a). Biomaterial-based scaffolds - current status and future directions. Expert Opin Drug Deliv 11:767–89
7. T.Garg, A.K.Goyal. (2014b). Liposomes: targeted and controlled delivery system. Drug Deliv Lett 4:62–71
8. T.Garg, A.Kumar, G.Rath, A.K.Goyal. (2014a). Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst 31:531–57
9. T.Garg, G.Rath, A.K.Goyal. (2014b). Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst 31:331–64
10. T.Garg, G.Rath, A.K.Goyal. (2014c). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv
11. T.Garg, O.Singh, S.Arora, R.Murthy. (2012b). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29:1–63
12. T.Garg, S.Singh, A.K.Goyal. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 30:369–409
13. T.Garg. (2014). Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol 1–8
14. A.K.Goyal, G.Rath, T.Garg. (2013a). Nanotechnological approaches for genetic immunization. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases 67–120
15. G.Goyal, T.Garg, B.Malik,. (2013b). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv
16. G.Goyal, T.Garg, G.Rath, A.K.Goyal. (2014a). Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst 31:89–119
17. G.Goyal, T.Garg, G.Rath, A.K.Goyal. (2014b). Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst 31:365–405
18. Y.L.Hao, Y.J.Deng, Y.Chen,. (2005). In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan. J Pharm Pharmacol 57:1279–87
19. T.Hussain, T.Garg, A.K.Goyal, G.Rath. (2014). Biomedical applications of nanofiber scaffolds in tissue engineering. J Biomim Biomater Tissue Eng 4:600–23
20. H.S.Johal, T.Garg, G.Rath, A.K.Goyal. (2014). Advanced topical drug delivery system for the management of Vaginal candidiasis. Drug Deliv 1–14
21. D.Joshi, T.Garg, A.K.Goyal, G.Rath. (2014). Advanced drug delivery approaches against periodontitis. Drug Deliv 1–15
22. K.Kataria, A.Sharma, T.Garg,. (2014). Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett 4:79–86
23. M.Kaur, T.Garg, R.K.Narang. (2014a). A review of emerging trends in the treatment of tuberculosis. Artif Cells Nanomed Biotechnol 1–7
24. M.Kaur, T.Garg, G.Rath, A.K.Goyal. (2014b). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31:49–88
25. M.Kaur, B.Malik, T.Garg,. (2014c). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv
26. N.Kaur, T.Garg, A.K.Goyal, G.Rath. (2014d). Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv 1–10
27. P.Kaur, T.Garg, G.Rath,. (2014e). Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv 1–12
28. R.Kaur, T.Garg, U.Das Gupta,. (2014f). Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol 1–6
29. R.Kaur, T.Garg, B.Malik,. (2014g). Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv 1–6
30. R.Kaur, T.Garg, G.Rath, A.K.Goyal. (2014h). Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst 31:495–530
31. V.Kaur, T.Garg, G.Rath, A.K.Goyal. (2014i). Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target 1–12
32. J.-H.Kim, Y.-S.Kim, S.Kim,. (2006). Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release 111:228–34
33. Y.-L.Lo. (2003). Relationships between the hydrophilic–lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Release 90:37–48
34. R.Malik, T.Garg, A.K.Goyal, G.Rath. (2014). Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target 1–16
35. H.Marwah, T.Garg, A.K.Goyal, G.Rath. (2014). Permeation enhancer strategies in transdermal drug delivery. Drug Deliv 1–15
36. W.Mehnert, K.Mäder. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–96
37. V.Modgill, T.Garg, A.K.Goyal, G.Rath. (2014). Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol 1–6
38. A.Morie, T.Garg, A.K.Goyal, G.Rath. (2014). Nanofibers as novel drug carrier - an overview. Artif Cells Nanomed Biotechnol 1–9
39. R.H.Muèller, K.Maèder, S.Gohla. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50:161–77
40. R.Müller, M.Radtke, S.Wissing. (2002a). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharmaceut 242:121–8
41. R.Müller, M.Radtke, S.Wissing. (2002b). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131–55
42. N.Nishiyama, K.Kataoka. (2006). Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Therapeut 112:630–48
43. S.Pabreja, T.Garg, G.Rath, A.K.Goyal. (2014). Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif Cells Nanomed Biotechnol 1–8
44. B.D.Rege, J.P.Kao, J.E.Polli. (2002). Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharmaceut Sci 16:237–46
45. J.Rejman, V.Oberle, I.Zuhorn, D.Hoekstra. (2004). Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377:159–69
46. R.Rohilla, T.Garg, A.K.Goyal, G.Rath. (2014). Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv 1–17
47. A.Sharma, T.Garg, A.Aman,. (2014a). Nanogel-an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol 1–13
48. R.Sharma, T.Garg, A.K.Goyal, G.Rath. (2014b). Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol 1–8
49. R.Sharma, H.Singh, M.Joshi,. (2014c). Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst 31:187–217
50. B.Singh, T.Garg, A.K.Goyal, G.Rath. (2014a). Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol 1–10
51. H.Singh, R.Sharma, M.Joshi,. (2014b). Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol
52. O.Singh, T.Garg, G.Rath, A.K.Goyal. (2014c). Microbicides for the treatment of sexually transmitted hiv infections. J Pharmaceut 1–18
53. K.Vivek, H.Reddy, R.S.Murthy. (2007). Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS Pharmscitech 8:16–24
54. T.Vohra, I.Kaur, H.Heer, R.R.Murthy. (2013). Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer. Cancer Nanotechnol 4:1–12
55. H.L.Wong, R.Bendayan, A.M.Rauth,. (2007). Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev 59:491–504